These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 12207740

  • 1. Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas.
    Lu D, Patel KA, Duvic M, Jones D.
    J Cutan Pathol; 2002 Sep; 29(8):465-72. PubMed ID: 12207740
    [Abstract] [Full Text] [Related]

  • 2. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R, Quaglino P, Novelli M, Fierro MT, Comessatti A, Peroni A, Bonello L, Bernengo MG.
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [Abstract] [Full Text] [Related]

  • 3. Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE).
    Wood GS, Tung RM, Haeffner AC, Crooks CF, Liao S, Orozco R, Veelken H, Kadin ME, Koh H, Heald P.
    J Invest Dermatol; 1994 Jul; 103(1):34-41. PubMed ID: 8027579
    [Abstract] [Full Text] [Related]

  • 4. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [Abstract] [Full Text] [Related]

  • 5. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
    Papadavid E, Economidou J, Psarra A, Kapsimali V, Mantzana V, Antoniou C, Limas K, Stratigos A, Stavrianeas N, Avgerinou G, Katsambas A.
    Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
    [Abstract] [Full Text] [Related]

  • 6. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK, Mullins FM, Kim YH, Kong CS.
    Cancer; 2008 Oct 25; 114(5):323-32. PubMed ID: 18798522
    [Abstract] [Full Text] [Related]

  • 7. Cutaneous T cell lymphomas: mycosis fungoides, Sezary syndrome and HTLV-I-associated adult T cell leukemia (ATL) in Mali, West Africa: a clinical, pathological and immunovirological study of 14 cases and a review of the African ATL cases.
    Fouchard N, Mahe A, Huerre M, Fraitag S, Valensi F, Macintyre E, Sanou F, de The G, Gessain A.
    Leukemia; 1998 Apr 25; 12(4):578-85. PubMed ID: 9557617
    [Abstract] [Full Text] [Related]

  • 8. Solitary skin lesions with histopathologic features of early mycosis fungoides.
    Cerroni L, Fink-Puches R, El-Shabrawi-Caelen L, Soyer HP, LeBoit PE, Kerl H.
    Am J Dermatopathol; 1999 Dec 25; 21(6):518-24. PubMed ID: 10608243
    [Abstract] [Full Text] [Related]

  • 9. Naïve/memory T-cell phenotypes in leukemic cutaneous T-cell lymphoma: Putative cell of origin overlaps disease classification.
    Horna P, Moscinski LC, Sokol L, Shao H.
    Cytometry B Clin Cytom; 2019 May 25; 96(3):234-241. PubMed ID: 30328260
    [Abstract] [Full Text] [Related]

  • 10. Comparative analysis of histological and immunohistological features in mycosis fungoides and Sézary syndrome.
    Kamarashev J, Burg G, Kempf W, Hess Schmid M, Dummer R.
    J Cutan Pathol; 1998 Sep 25; 25(8):407-12. PubMed ID: 9826165
    [Abstract] [Full Text] [Related]

  • 11. [Clinicomorphological characteristics of Sezary's disease and mycosis fungoides].
    Vinogradova IuE, Giliazitdinova EA, Zamulaeva IA, Zybunova EE, Kaplanskaia IB, Kravchenko SK, Kremenetskaia AM, Lutsenko IN, Samoĭlova RS, Selivanova EN, Sidorova IuV, Shklovskiĭ-Kord NE.
    Ter Arkh; 2005 Sep 25; 77(10):61-5. PubMed ID: 16320688
    [Abstract] [Full Text] [Related]

  • 12. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior.
    Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R.
    Am J Pathol; 1999 Aug 25; 155(2):483-92. PubMed ID: 10433941
    [Abstract] [Full Text] [Related]

  • 13. Determination of immunophenotypic aberrancies provides better assessment of peripheral blood involvement by mycosis fungoides/Sézary syndrome than quantification of CD26- or CD7- CD4+ T-cells.
    Lyapichev KA, Bah I, Huen A, Duvic M, Routbort MJ, Wang W, Jorgensen JL, Medeiros LJ, Vega F, Craig FE, Wang SA.
    Cytometry B Clin Cytom; 2021 Mar 25; 100(2):183-191. PubMed ID: 32667737
    [Abstract] [Full Text] [Related]

  • 14. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH, Tensen CP, van der Stoop PM, van Oostveen HW, Lund M, Scheper RJ, Willemze R.
    Arch Dermatol; 2001 Jul 25; 137(7):901-5. PubMed ID: 11453809
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.
    Nguyen GH, Olson LC, Magro CM.
    Ann Diagn Pathol; 2017 Jun 25; 28():54-59. PubMed ID: 28648940
    [Abstract] [Full Text] [Related]

  • 19. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM, Cerroni L.
    Am J Dermatopathol; 2015 Feb 25; 37(2):115-21. PubMed ID: 25406852
    [Abstract] [Full Text] [Related]

  • 20. Prognostic factors in 105 Japanese cases of mycosis fungoides and Sézary syndrome: clusterin expression as a novel prognostic factor.
    Tobisawa S, Honma M, Ishida-Yamamoto A, Saijo Y, Iizuka H.
    J Dermatol Sci; 2013 Sep 25; 71(3):160-6. PubMed ID: 23702390
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.